Teva Pharmaceuticals USA is recalling 18,850 units of Methylprednisolone Acetate Injectable Suspension and Norepinephrine Bitartrate Injection. The recall was initiated because the products may not be sterile, which can lead to serious health complications. No incidents or injuries have been reported to date. These medications were distributed to hospitals and pharmacies in Mississippi, Ohio, and Tennessee.
Injectable medications that are not sterile can cause severe, life-threatening systemic infections. Because these drugs are administered directly into the body, any contamination poses a high risk to patient safety.
Sterility assurance failure
Manufactured for Northstar Rx LLC; packaged in cartons.
10 vials per carton.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.